An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases

LM Filgueira, JB Cervantes, OA Lovelle, C Herrera… - …, 2021 - Taylor & Francis
cytokines release, including IFN-γ, IL-6 and TNF-α. Here, we report the outcome of three
severe and critically ill COVID-19 … Itolizumab was able to reduce IL-6 concentrations in all the …

Prolonged NHE activation may be both cause and outcome of cytokine release syndrome in COVID-19

MC Cure, E Cure - Current Pharmaceutical Design, 2022 - ingentaconnect.com
… ill patients with COVID-19. Excessive cytokine release during COVID-19 is related to …
Several mechanisms are put forward for cytokine release syndrome during COVID-19. Here …

Tocilizumab: the key to stop coronavirus disease 2019 (COVID-19)-Induced cytokine release syndrome (CRS)?

D Liu, T Zhang, Y Wang, L Xia - Frontiers in medicine, 2020 - frontiersin.org
… underlying the cytokine release syndrome induced by IL-6 elevation in COVID-19 patients.
In … response while maintaining pro-inflammatory cytokines production. Besides, the count of …

[HTML][HTML] Macrophage activation and cytokine release syndrome in COVID-19: current updates and analysis of repurposed and investigational anti-cytokine drugs

A Iqubal, F Hoda, AK Najmi, SE Haque - Drug Research, 2021 - thieme-connect.com
Cytokine release syndrome (CRS) or cytokine storm is a term used to affiliate the situation of
hyper inflammation and therefore use of anti-cytokine … the immunopathology of COVID-19 is …

Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case …

F Faqihi, A Alharthy, R Alshaya, J Papanikolaou… - BMC cardiovascular …, 2020 - Springer
… Fulminant (life-threatening) COVID-19 can be associated with acute respiratory failure (ARF)…
and cytokine release syndrome (CRS). We present a rare case of fulminant COVID-19

Case study: a patient with asthma, Covid-19 pneumonia and cytokine release syndrome treated with corticosteroids and tocilizumab

GK Schleicher, W Lowman… - Wits Journal of Clinical …, 2020 - journals.co.za
… or exacerbation of chronic obstructive pulmonary disease.(4) … Covid-19 infection, progressive
pneumonia, development of a hyperinflammatory state and cytokine release syndrome

The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease

R Pasrija, M Naime - International Immunopharmacology, 2021 - Elsevier
COVID-19 caused by the SARS-CoV-2 virus, accompanies an unprecedented spike in
cytokines levels termed cytokines release syndrome (CRS), in critically ill patients. Clinicians …

… replacement therapy with oXiris filter may not be an effective resolution to alleviate cytokine release syndrome in non-AKI patients with severe and critical COVID-19

K Kang, Y Luo, Y Gao, J Zhang, C Wang… - Frontiers in …, 2022 - frontiersin.org
cytokine release syndrome (CRS) in non-AKI patients with severe and critical coronavirus
disease 2019 (COVID-19)… A total of 17 non-AKI patients with severe and critical COVID-19

COVID-19-induced cytokine release syndrome associated with pulmonary vein thromboses, atrial cardiomyopathy, and arterial intima inflammation

A Goette, M Patscheke, F Henschke… - TH open, 2020 - thieme-connect.com
… levels of inflammatory cytokines might be involved in the development of organ dysfunction
in COVID-19. Here, we can present a case of cytokine release syndrome induced by SARS–…

… cohort single‐center study evaluating outcomes of COVID19 and the impact of immunomodulation on COVID19‐related cytokine release syndrome in solid organ …

M Ringer, V Azmy, K Kaman, D Tang… - … Infectious Disease, 2021 - Wiley Online Library
… Lastly, the complex cytokine release syndrome in COVID-19 remains an area of intense
research and the analysis of key interleukin levels (IL-6, IL-10, and sIL2R) in this study …